In contrast, treatment and prevention of most cancers require robust and diverse cytotoxic CD8+ T cells to directly debulk primary or metastatic tumor burdens, which are composed of heterogeneous tumor cells expressing many tumor antigens. Here, CD8A is linked to neoplasm.